Lupron and Pulmonary infarction - a phase IV clinical study of FDA data

Summary:

Pulmonary infarction is reported as a side effect among people who take Lupron (leuprolide acetate), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Nuvaring, and have Birth control.

The phase IV clinical study analyzes which people have Pulmonary infarction when taking Lupron. It is created by eHealthMe based on reports of 41,483 people who have side effects when taking Lupron from the FDA, and is updated regularly.

What is Lupron?

Lupron has active ingredients of leuprolide acetate. It is often used in endometriosis. eHealthMe is studying from 42,122 Lupron users. Check the latest studies of Lupron.

What is Pulmonary infarction?

Pulmonary infarction (death of a small area of lung) is found to be associated with 392 drugs and 621 conditions by eHealthMe. Check the latest studies of Pulmonary infarction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

41,483 people reported to have side effects when taking Lupron.
Among them, 19 people (0.05%) have Pulmonary infarction.

Could Lupron cause Pulmonary infarction?

Among these 19 people:

How long have people been on Lupron when they have Pulmonary infarction? *

What is the gender of people who have Pulmonary infarction when taking Lupron? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Pulmonary infarction when taking Lupron? *

What are other drugs people take besides Lupron? *

Nuvaring: 7 people, 36.84%
Bisoprolol Fumarate: 3 people, 15.79%
Famotidine: 3 people, 15.79%
Prednisolone: 3 people, 15.79%
Yasmin: 2 people, 10.53%
Drospirenone And Ethinyl Estradiol: 2 people, 10.53%
Yaz: 2 people, 10.53%
Olanzapine: 1 person, 5.26%
Cabometyx: 1 person, 5.26%
Captopril: 1 person, 5.26%

What are other side effects people have besides Pulmonary infarction? *

Pulmonary Embolism (blockage of the main artery of the lung): 11 people, 57.89%
Joint Pain: 8 people, 42.11%
Nausea (feeling of having an urge to vomit): 8 people, 42.11%
Stress And Anxiety: 8 people, 42.11%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 42.11%
Pneumonia: 6 people, 31.58%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 6 people, 31.58%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 6 people, 31.58%
Chest Pain: 6 people, 31.58%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 31.58%

What are the existing conditions these people have? *

Birth Control: 5 people, 26.32%
Uterine Haemorrhage (uterine bleeding): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Lupron and have Pulmonary infarction?

- Check whether Pulmonary infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lupron:

Lupron (42,122 reports)

Browse all side effects of Lupron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary infarction:

Pulmonary infarction (392 drugs)

Browse all the conditions that are associated with Pulmonary infarction:

Pulmonary infarction (621 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Lupron) and Lupron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.